Memorial Hermann runs a strategic investments, partnerships and innovation function that takes equity positions in healthcare companies whose products the system can deploy. The program organizes around two objectives: strengthening core inpatient and outpatient care delivery, and augmenting illness prevention through early access, holistic health and wellness interventions. Priority themes include patient experience, health equity, access, high-reliability care delivery, digital and analytics innovation, and the transition to value-based care. The system has disclosed a portfolio of more than 40 companies, one of the largest published provider portfolios in the country. Investments are typically paired with commercial deployment inside Memorial Hermann.
Documented successes: Publicly discloses a portfolio of more than 40 companies including Transcarent, Truveta, Cedar, Clarify Health, Capital Rx, Hippocratic AI, Rad AI, Monogram Health, Memora Health, Hazel Health, Firefly Health, Laudio, Koda Health, Reimagine Care, Xealth, Zocdoc, Wellvana, Helix and Carta Healthcare; participated in Xealth's $24 million Series B; took a stake alongside Intermountain and Trinity Health in a $300 million private equity fund